These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging. Pettersson H; Ackerman N; Kaude J; Googe RE; Mancuso AA; Scott KN; Hackett RH; Hager DA; Caballero S Acta Radiol; 1987; 28(1):75-8. PubMed ID: 2952147 [TBL] [Abstract][Full Text] [Related]
43. Magnetic resonance tumor targeting imaging using gadolinium labeled human telomerase reverse transcriptase antisense probes. Ren BX; Yang F; Zhu GH; Huang ZX; Ai H; Xia R; Liu XJ; Lu M; Song B Cancer Sci; 2012 Aug; 103(8):1434-9. PubMed ID: 22534012 [TBL] [Abstract][Full Text] [Related]
44. Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. Schaefer S; Malloy CR; Katz J; Parkey RW; Buja LM; Willerson JT; Peshock RM J Am Coll Cardiol; 1988 Oct; 12(4):1064-72. PubMed ID: 3417979 [TBL] [Abstract][Full Text] [Related]
45. Synthesis of DTPA analogues derived from piperidine and azepane: potential contrast enhancement agents for magnetic resonance imaging. Chong HS; Garmestani K; Bryant LH; Brechbiel MW J Org Chem; 2001 Nov; 66(23):7745-50. PubMed ID: 11701031 [TBL] [Abstract][Full Text] [Related]
46. Synthesis and physicochemical characterization of two gadolinium(III) TTDA-like complexes and their interaction with human serum albumin. Ou MH; Tu CH; Tsai SC; Lee WT; Liu GC; Wang YM Inorg Chem; 2006 Jan; 45(1):244-54. PubMed ID: 16390062 [TBL] [Abstract][Full Text] [Related]
47. A new biodegradable and biocompatible gadolinium (III) -polymer for liver magnetic resonance imaging contrast agent. Xiao Y; Xue R; You T; Li X; Pei F Magn Reson Imaging; 2015 Jul; 33(6):822-8. PubMed ID: 25839395 [TBL] [Abstract][Full Text] [Related]
48. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent. Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510 [TBL] [Abstract][Full Text] [Related]
49. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Weinmann HJ; Brasch RC; Press WR; Wesbey GE AJR Am J Roentgenol; 1984 Mar; 142(3):619-24. PubMed ID: 6607655 [TBL] [Abstract][Full Text] [Related]
50. Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA). Brugières P; Gaston A; Degryse HR; Parizel PM; de Schepper AM; Berry I; Manelfe C; Le Bras F; Marsault C; Wichmann W Neuroradiology; 1994; 36(1):27-30. PubMed ID: 8107991 [TBL] [Abstract][Full Text] [Related]
51. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver. Pavone P; Patrizio G; Buoni C; Tettamanti E; Passariello R; Musu C; Tirone P; Felder E Radiology; 1990 Jul; 176(1):61-4. PubMed ID: 2353112 [TBL] [Abstract][Full Text] [Related]
52. Aerosolized gadolinium-DTPA enhances the magnetic resonance signal of extravascular lung water. Montgomery AB; Paajanen H; Brasch RC; Murray JF Invest Radiol; 1987 May; 22(5):377-81. PubMed ID: 3597005 [TBL] [Abstract][Full Text] [Related]
53. Hydrated clearance of gadolinium-DTPA as a measurement of glomerular filtration rate. Choyke PL; Austin HA; Frank JA; Girton ME; Diggs RL; Dwyer AJ; Miller L; Nussenblatt R; McFarland H; Simon T Kidney Int; 1992 Jun; 41(6):1595-8. PubMed ID: 1501414 [TBL] [Abstract][Full Text] [Related]
54. New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues. Cyran CC; Fu Y; Raatschen HJ; Rogut V; Chaopathomkul B; Shames DM; Wendland MF; Yeh BM; Brasch RC J Magn Reson Imaging; 2008 Mar; 27(3):581-9. PubMed ID: 18219614 [TBL] [Abstract][Full Text] [Related]
55. Interference of magnetic resonance imaging contrast agents with the serum calcium measurement technique using colorimetric reagents. Lin J; Idee JM; Port M; Diai A; Berthommier C; Robert M; Raynal I; Devoldere L; Corot C J Pharm Biomed Anal; 1999 Dec; 21(5):931-43. PubMed ID: 10703961 [TBL] [Abstract][Full Text] [Related]
56. From the relaxivity of Gd(DTPA)2- to everything else. Koenig SH Magn Reson Med; 1991 Dec; 22(2):183-90. PubMed ID: 1812344 [TBL] [Abstract][Full Text] [Related]
57. Cyclen-based Gd Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196 [TBL] [Abstract][Full Text] [Related]
58. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174 [TBL] [Abstract][Full Text] [Related]